x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

touchPODCAST

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare

science

All Episodes

42:42

Personalized treatment of RET-altered thyroid cancers

touchPODCAST ·

2022/03/16

touchEXPERT OPINIONS for touchENDOCRINOLOGY Listen to leading experts explain the value of biomarker testing and targeted therapies for the personalized treatment of RET-altered thyroid cancers The experts Prof. Maria Cabanillas - University of Texas MD Anderson Cancer Center, Houston, TX, USA Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, TX, USA Dr Lori Wirth - Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, MA, USA This touchPODCAST is for

en

12:57

Focus on cognitive impairment in the diagnosis and...

touchPODCAST ·

2022/03/15

touchMDT for touchNEUROLOGY Listen to experts with multidisciplinary perspectives share their expert insights on the impact of cognitive dysfunction in relapsing MS, and how to best assess and manage the associated cognitive symptoms. The multidisciplinary team Neurologist/MS specialist: Prof. Mark Freedman, Canada Clinical psychologist/MS educator: Dr Rosalind Kalb, USA Neuropsychologist: Prof. Dawn Langdon, UK Advanced practice clinician: Ms Amy Perrin Ross, USA This touchPODCAST is for HCPs

en

11:52

Focus on cognitive impairment in the diagnosis and...

touchPODCAST ·

2022/03/15

touchMDT for touchNEUROLOGY Listen to experts with multidisciplinary perspectives discuss the current treatment landscape for relapsing MS and how oral DMTs can improve patient outcomes. The multidisciplinary team Neurologist/MS specialist: Prof. Mark Freedman, Canada Clinical psychologist/MS educator: Dr Rosalind Kalb, USA Advanced practice clinician: Ms Amy Perrin Ross, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from

en

11:09

Focus on cognitive impairment in the diagnosis and...

touchPODCAST ·

2022/03/15

touchMDT for touchNEUROLOGY Listen to experts with multidisciplinary perspectives, discuss the importance of early diagnosis of relapsing MS for improved long-term patient outcomes. The multidisciplinary team Neurologist/MS specialist: Prof. Mark Freedman, Canada Clinical psychologist/MS educator: Dr Rosalind Kalb, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by

en

17:14

MDT and patient perspectives on the importance of...

touchPODCAST ·

2022/03/11

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient discuss the benefits of early treatment intensification and weight loss for patients with T2D and obesity as well as the importance of effective patient education strategies. The multidisciplinary team and patient Diabetes care & education specialist: Ms Jennifer Okemah, Kirkland, WA Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA Patient: Ms Brittany Jones, Atlanta, GA This

en

14:31

MDT and patient perspectives on GLP-1 RA therapy and...

touchPODCAST ·

2022/03/11

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient explore the use of GLP-1 RA therapy to treat T2D and obesity, including observations from a patient’s perspective, and consider the evidence for incretin-based dual agonists in development The multidisciplinary team and patient Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA Endocrinologist (obesity): Dr Ken Fujioka, San Diego, CA Patient: Ms Brittany Jones, Atlanta, GA This

en

09:30

MDT perspectives on the role of incretin hormones in...

touchPODCAST ·

2022/03/11

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team discuss the role of incretin hormones in healthy individuals and in those with T2D and share insights from the latest research in this field The multidisciplinary team Endocrinologist (obesity): Dr Ken Fujioka, San Diego, CA Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Eli

en

33:28

Targeting the pathobiology of ESCC: Potential impact...

touchPODCAST ·

2022/03/09

touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts provide an update on the underlying pathobiology of esophageal squamous cell carcinoma, and review current and emerging therapies. The experts Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan Dr Jean-Phillippe Metges, Brest University Hospital, Brest, France Dr Radka Obermannova, Masaryk Memorial Cancer Institute Brno, Czech Republic This touchPODCAST is for HCPs only. This activity is funded by an unrestricted

en

32:08

The evolving role of antibody–drug conjugates in the...

touchPODCAST ·

2022/01/31

Listen to a genitourinary cancer expert outline the use of antibody–drug conjugates in the treatment of urothelial carcinoma, including their place in current treatment guidelines, clinical trial data and the management of possible adverse events. The expert Dr Cora Sternberg, Weill Cornell Medicine, New York, NY, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Gilead Sciences and Seagen. This activity is jointly provided

en

16:04

MDT and patient perspectives on the long-term...

touchPODCAST ·

2022/01/26

touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss evidence-based guidance for the long-term management of patients with severe type 2 asthma. The multidisciplinary team Pulmonologist: Professor Alberto Papi, Italy Allergist: Professor Ioana Agache, Romania Primary care physician: Professor Barbara Yawn, USA Patient: Ms JoJo O’Neal, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted

en

13:55

MDT and patient perspectives on the disease burden of...

touchPODCAST ·

2022/01/26

touchMDT for touchIMMUNOLOGY Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss the daily challenges of living with severe asthma for patients and their families. The multidisciplinary team Primary care physician: Professor Barbara Yawn, USA Allergist: Professor Ioana Agache, Romania Patient: Ms JoJo O’Neal, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Regeneron

en

16:22

MDT perspectives on biologic treatment selection in...

touchPODCAST ·

2022/01/26

touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team explore the use of endotyping and biomarkers in guiding biologic treatment selection for patients with severe type 2 asthma. The multidisciplinary team Allergist: Professor Ioana Agache, Romania Primary care physician: Professor Barbara Yawn, USA Pulmonologist: Professor Alberto Papi, Italy This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from

en

13:50

MDT and patient perspectives on the disease burden of...

touchPODCAST ·

2022/01/26

touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss the daily challenges of living with severe asthma for patients and their families. The multidisciplinary team Primary care physician: Professor Barbara Yawn, USA Allergist: Professor Ioana Agache, Romania Patient: Ms JoJo O’Neal, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Regeneron

en

16:29

MDT perspectives on biologic treatment selection in...

touchPODCAST ·

2022/01/26

touchMDT for touchIMMUNOLOGY Listen to key experts from a multidisciplinary team explore the use of endotyping and biomarkers in guiding biologic treatment selection for patients with severe type 2 asthma. The multidisciplinary team Allergist: Professor Ioana Agache, Romania Primary care physician: Professor Barbara Yawn, USA Pulmonologist: Professor Alberto Papi, Italy This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Regeneron

en

01:01:06

Advancing the treatment of MDS and AML: An update...

touchPODCAST ·

2022/01/24

touchCONGRESS for touchONCOLOGY Listen to Prof. Pierre Fenaux (France) review key data presented at ASH 2021 on emerging treatments for patients with higher-risk MDS and newly diagnosed AML and offer his insights on their potential impact on future clinical practice, alongside those from Dr Esther Oliva (Italy) and Prof. Andrew Wei (Australia). OVERVIEW Data review with Prof. Fenaux (0:00) Expert interviews with Prof. Fenaux, Dr Oliva and Prof. Wei, answering the questions below INTERVIEW

en

33:57

Immunotherapy for recurrent or metastatic head and...

touchPODCAST ·

2022/01/24

touchPANEL DISCUSSION for touchONCOLOGY Listen to three experts as they explore key clinical considerations when using immune checkpoint inhibitors to treat recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). The discussion includes the current role of immune checkpoint inhibitors, factors that may inform treatment decisions and approaches for managing side effects associated with immune checkpoint inhibitors. The experts Prof. Kevin Harrington – The Institute of Cancer Research,

en

33:31

HPV infection and TGF-β: Translating the science into...

touchPODCAST ·

2022/01/20

touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts consider the current treatment options and unmet needs for patients with HPV-associated cancers, the link between HPV and TGF-β, and how this is driving the development of new treatments. The experts Dr Judith Michels, Institut Gustave Roussy, Villejuif, France Dr Andrew Sikora, MD Anderson Cancer Center, Houston, TX, USA Dr Krishnansu Tewari, University of California, Irvine, CA, USA This touchPODCAST is for HCPs only. This activity

en

16:09

MDT and patient perspectives on the long-term...

touchPODCAST ·

2022/01/14

touchMDT for touchIMMUNOLOGY Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss evidence-based guidance for the long-term management of patients with severe type 2 asthma. The multidisciplinary team Pulmonologist: Professor Alberto Papi, Italy Allergist: Professor Ioana Agache, Romania Primary care physician: Professor Barbara Yawn, USA Patient: Ms JoJo O’Neal, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted

en

34:41

Immune checkpoint inhibitors in prostate cancer:...

touchPODCAST ·

2022/01/13

touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts consider the current role of immune checkpoint inhibitors in prostate cancer and possible future directions. The experts Prof. Karim Fizazi - Gustave Roussy, Villejuif, France Dr Sandy Srinivas - Stanford University, Stanford, CA, USA Prof. Johann de Bono - The Institute of Cancer Research, London, UK This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Merck Sharp &

en

22:14

Targeting the pathobiology of ESCC: Potential impact...

touchPODCAST ·

2021/12/06

touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts provide an update on the underlying pathobiology of esophageal squamous cell carcinoma, and review current and emerging therapies. The experts Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan Dr Jean-Phillipe Metges, University Hospital of Brest, Brest, France This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME. For

en

532 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter